|
 |
 |
|
 |
 |
MAY
30, 2008
Bench to Bedside: Innovative Approaches
to Hematologic Malignancies
An Independent Satellite Symposium Held Adjunct to the 44th ASCO® Annual Meeting
Chicago, Illinois
Hyatt Regency Chicago (Wacker Drive)
Grand Ballroom A - D
6:30 pm – 8:30 pm
Chair:
Rafael
Fonseca, MD
Mayo Clinic
Scottsdale, Arizona
Click
here to register
for this program
|
 |
| F
A C U L T Y |
 |
|
Benjamin Levine Ebert, MD
Harvard Medical School
Boston, Massachusetts
Rafael Fonseca, MD
Mayo Clinic
Scottsdale, Arizona |
John P. Leonard, MD
Weill Medical College
Cornell University
New York, New York
Sagar Lonial, MD
Winship Cancer Institute
Emory University
Atlanta, Georgia |
Susan O’Brien, MD
MD Anderson Cancer Center
Houston, Texas |
|
|
| S
C I E N T I F I C A G E N D A |
|
|
Friday, May
30, 2008
6:30 pm
Welcome and introduction
Rafael Fonseca, MD
6:35 pm
Advances in therapy for multiple myeloma
Sagar Lonial, MD
6:55 pm
Advances in therapy for relapsed/refractory follicular non-Hodgkin’s lymphoma
John P. Leonard, MD
7:15 pm
Advances in the management of chronic lymphocytic leukemia
Susan O’Brien, MD
7:35 pm
Molecular-genomic stratifi cation in the management of MDS
Benjamin Levine Ebert, MD
7:55 pm
Panel discussion of case presentations: Future therapeutic directions for hematologic malignancies
Rafael Fonseca, MD
8:25 pm
Summary and take home messages from the chair
8:30 pm
Adjourn |
|
|
| W
H O S H O U L D A T T E N
D |
|
|
| This educational activity is specifically designed for hematologists,oncologists, internists and other physicians, physicians in-training, nurses and related healthcare professionals interested and/or involved in the care of patients with hematologic malignancies. |
|
|
| O
B J E C T I V E S |
|
|
After
successful completion of this course, attendees
should be able to:
- Examine the role of lenalidomide,
bortezomib and doxorubicin in the management
of multiple myeloma, and how they may
be incorporated into standard induction
chemotherapy regimens
- List the current treatment modalities
for the management of patients with
relapsed multiple myeloma
- Compare and contrast the various
combinations of agents available for
treatment of relapsed/refractory non-Hodgkin
lymphoma
- List
the new agents available for the
treatment of non-Hodgkin lymphoma
and assess their role in current disease
management
- Discuss
and describe the emerging data regarding
the importance and management of
minimal residual disease in chronic
lymphocytic leukemia
- Integrate
novel agents and new therapy combinations
into the clinical management of chronic
lymphocytic leukemia
- Discuss
the role of genomic profiling in
the stratification of myelodysplastic
syndromes and apply that knowledge
towards effective treatment planning
- Implement
current clinical trial data into
the treatment of multiple myeloma,
non-Hodgkin lymphoma, chronic lymphocytic
leukemia and myelodysplastic syndromes
to improve patient management strategies
|
|
|
|
C O N T I N U I
N G M E D I C A
L E D U C A T I O N |
|
|
Imedex, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Imedex, LLC designates this educational activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. |
|
|
|
R E G
I S T
R A T
I O N |
|
|
Click
here to register
for this program
This is a complimentary educational dinner symposium and space is limited.
To pre-register, registration must be received no later than May 12, 2008. Please register onsite after this date. Contact Imedex at +1 (678) 242 0906 or visit our website at www.imedex.com to ensure that the program is being held as scheduled and to confirm that the meeting is not full.
Imedex does not accept responsibility for covering travel, accommodation or any other costs incurred by registrants in the rare event that this symposium should be canceled for any reason. Every effort will be made to give reasonable notice in the event of cancellation. The event agenda content is subject to change without notice. |
|
|
| G E N E R A L I N F O R M A T I O N |
|
|
Symposium Location
Hyatt Regency Chicago
Grand Ballroom A - D
151 East Wacker Drive
Chicago, Illinois 60601
Tel: + 1 (312) 565 1234
www.chicagohyatt.com
©2008 Imedex®, LLC. All rights reservUed. Reproduction in whole or part is prohibited without prior written consent from Imedex and contributing faculty. |
|
|
| O
R G A N I Z E R |
|
|
|
| ©
2008 Imedex®, LLC |
|
